PFPC Daily - January 12, 2005

Crestor death link confirmed

The Scotsman - Jan. 11, 2005

ASTRAZENECA, Europe's third largest drugmaker, has confirmed that
its cholesterol-lowering drug Crestor has been linked to the death of
a patient.

The death, possibly due to the severe muscle-wasting condition
rhabdomyolysis, has been reported to regulators worldwide, company
spokesman Steve Brown said.

Mr Brown said the circumstances surrounding the death, which occurred
in the latter part of 2004, were complicated and the company still
believed Crestor's safety profile was similar to that of other
so-called statin drugs.

He declined to say where the death occurred or what dose of Crestor
the patient had been taking. Crestor is the Anglo-Swedish
company's most important new drug but the product has been dogged
by allegations over its safety.

SOURCE:
http://business.scotsman.com/technology.cfm?id=32242005

Related:

CBS News: New Crestor Death Reported
http://tinyurl.com/6omqr

Financial Times: Crestor gives AstraZeneca a big headache
http://tinyurl.com/4ugsr